Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Lovat

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Cancer Research|February 22, 2012
miRNA signatures associate with pathogenesis and progression of osteosarcomaKevin B Jones, Zaidoun Salah, Sara Del Mare, et al.
Nature Medicine|December 14, 2011
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Cancer Research|September 14, 2018
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced CachexiaFederica Calore, Priya Londhe, Paolo Fadda, et al.
Nature Medicine|October 4, 2022
Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Blood|November 20, 2012
Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomasEugenio Gaudio, Francesco Paduano, Apollinaire Ngankeu, et al.
EMBO Molecular Medicine|April 24, 2013
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancerMaura Sonego, Monica Schiappacassi, Sara Lovisa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseMuller Fabbri, Alessio Paone, Federica Calore, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2013
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesisAndrea Vecchione, Barbara Belletti, Francesca Lovat, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinomaErika Testa, Clara Dezi, Francesca Lovat, et al.
Cancer Research|June 8, 2017
Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma ProgressionLucia Casadei, Federica Calore, Chad J Creighton, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cancer Research|February 22, 2012
miRNA signatures associate with pathogenesis and progression of osteosarcomaKevin B Jones, Zaidoun Salah, Sara Del Mare, et al.
Nature Medicine|December 14, 2011
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Cancer Research|September 14, 2018
The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced CachexiaFederica Calore, Priya Londhe, Paolo Fadda, et al.
Nature Medicine|October 4, 2022
Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Blood|November 20, 2012
Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomasEugenio Gaudio, Francesco Paduano, Apollinaire Ngankeu, et al.
EMBO Molecular Medicine|April 24, 2013
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancerMaura Sonego, Monica Schiappacassi, Sara Lovisa, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2012
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseMuller Fabbri, Alessio Paone, Federica Calore, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2013
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesisAndrea Vecchione, Barbara Belletti, Francesca Lovat, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinomaErika Testa, Clara Dezi, Francesca Lovat, et al.
Cancer Research|June 8, 2017
Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma ProgressionLucia Casadei, Federica Calore, Chad J Creighton, et al.
Pageof 6